This information is intended for use by health professionals
1. Name of the medicinal product
Glycerol 2g Suppositories
2. Qualitative and quantitative composition
Each suppository contains 1400mg GlycerolFor full list of excipients, see 6.1.
3. Pharmaceutical form
Amber coloured suppository, of nominal weight 2g intended for rectal administration.
4. Clinical particulars
4.1 Therapeutic indications
For occasional use as a stimulant laxative for the treatment of constipation.
4.2 Posology and method of administration
For rectal use
ChildrenOne 2g suppository, to aid insertion the suppository tip should be moistened with water before use.
• Hypersensitivity to the active substance(s) or to any of the excipients.• The product is contraindicated if there is intestinal obstruction or blockage.
4.4 Special warnings and precautions for use
The product is intended for occasional use only. Prolonged or excessive use of the product is not recommended as this may cause diarrhoea. Use of this product may interfere with glucose control in diabetic patients. If symptoms persist consult a doctor.
4.5 Interaction with other medicinal products and other forms of interaction
No interaction studies have been performed
4.6 Pregnancy and lactation
No evidence of harmful affects available. However, best avoided during the first trimester of pregnancy. May be used during breast feeding.
4.7 Effects on ability to drive and use machines
4.8 Undesirable effects
Use of the product may occasionally cause abdominal cramps. Glycerol can cause irritation when given rectally.
Overdosage via rectal route is unlikely. However, if ingested treat symptomatically.
5. Pharmacological properties
5.1 Pharmacodynamic properties
ATC code A06AX01 Glycerol is commonly classified as an osmotic laxative but may act additionally or alternatively by promoting peristalsis and evacuation of the lower bowel by virtue of a mild irritant effect. Glycerol suppositories possess also lubricating and faecal softening actions.
5.2 Pharmacokinetic properties
Glycerol following rectal administration is poorly absorbed.
5.3 Preclinical safety data
There are no preclinical data of relevance to the prescriber, which are additional to those already included in other sections of the SmPC
6. Pharmaceutical particulars
6.1 List of excipients
Gelatin Purified Water
6.3 Shelf life
6.4 Special precautions for storage
Store below 25°C in a dry place
6.5 Nature and contents of container
Heat sealed cavities composed of Polyvinyl Chloride (PVC) coated with Polyvinylidene Chloride (PVDC) and laminated with polyethylene (PE), each containing 1x 4g suppository in strips of 6. The strips and a patient leaflet are packed into cardboard cartons. Pack size available: 12 x 4g.
6.6 Special precautions for disposal and other handling
Wash hands before opening individual packaging. The suppository is shaped for rectal insertion, ensure the tip of the suppository is inserted first. The tip should be moistened with a little cold water to aid insertion.
7. Marketing authorisation holder
Martindale Pharmaceuticals Ltd.Bampton Road, Romford, RM3 8UGUnited Kingdom
8. Marketing authorisation number(s)
9. Date of first authorisation/renewal of the authorisation
10. Date of revision of the text